IAM Pharma & Biotech IP Summit 2020
The life sciences are in a period of dramatic change and innovation with developments in new technologies challenging traditional IP strategies and business models. IAM’s Pharma and Biotech IP will bring together leading in-house practitioners and expert counsel to discuss next-generation strategies for protecting and exploiting cutting-edge innovation.
HGF Partner Douglas Drysdale will be attending and joining a panel to discuss Protecting the next generation of therapies:
A wave of cutting-edge technologies – from personalised medicines to gene and cell therapies – have become the focus of innovation in the life sciences, raising new challenges for IP professionals. An expert panel will shed light on:
- The patentability questions raised by new technologies
- How to gain the strongest possible protection for these technologies
- Relevant international differences
HGF Patent Director Dr Emma Longland will also be attending.
Click here to register and find out more about the event.